Business
This new weight-loss medicine is flying off the shelves – The Australian Financial Review
Novo Nordisk, best-known for diabetes treatments, is using Wegovy to treat the global obesity epidemic – a related chronic ailment…
Patients are flocking to the first new obesity medicine to reach the market in years, boosting returns for drug maker Novo Nordisk.
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients…
Continue Reading
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business23 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News22 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers